Cargando…

Gene polymorphisms and serum levels of sVEGFR-1 in patients with systemic lupus erythematosus

Correlation between soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) concentration, VEGFR1 gene polymorphisms and systemic lupus erythematosus (SLE) risk remains unclear. The present case–control study comprised 254 SLE patients, 385 other rheumatic diseases patients and 390 healthy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Zhi-Chao, Xu, Wang-Dong, Wang, Jia-Min, Wu, Qian, Zhou, Jie, Huang, An-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490265/ https://www.ncbi.nlm.nih.gov/pubmed/32929141 http://dx.doi.org/10.1038/s41598-020-72020-8

Ejemplares similares

Serum levels and gene polymorphisms of angiopoietin 2 in systemic lupus erythematosus patients
por: Wang, Jia-Min, et al.
Publicado: (2021)

Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients
por: Zarychta, Elżbieta, et al.
Publicado: (2023)

PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GIST
por: Hansson, E K, et al.
Publicado: (2013)

Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
por: Şalk, Sultan, et al.
Publicado: (2022)

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice
por: Kujala, Anni, et al.
Publicado: (2022)

Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis
por: Debrah, Alexander Yaw, et al.
Publicado: (2006)

sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?
por: Spearman, Andrew D., et al.
Publicado: (2021)

The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use
por: Wu, Florence T H, et al.
Publicado: (2010)

Commentary: sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?
por: Putotto, Carolina, et al.
Publicado: (2021)

Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy
por: Jürgensmeier, J M, et al.
Publicado: (2013)

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
por: Robak, Ewa, et al.
Publicado: (2003)

The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus
por: Chen, Jian-Ming, et al.
Publicado: (2015)

BAFF polymorphisms and serum levels of BAFF in Tunisian systemic lupus erythematosus patients
por: Laamiri, Nacira, et al.
Publicado: (2012)

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
por: Abou Faycal, Cherine, et al.
Publicado: (2018)

IL‐38: A novel cytokine in systemic lupus erythematosus pathogenesis
por: Xu, Wang‐Dong, et al.
Publicado: (2020)

Evaluation of the effects of different treatment modalities on angiogenesis in heart failure patients with reduced/mid-range ejection fraction via VEGF and sVEGFR-1
por: Erturk, Ismail, et al.
Publicado: (2018)

Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus
por: Xu, Wang‐Dong, et al.
Publicado: (2020)

Serum Midkine Levels in Systemic Lupus Erythematosus
por: Marpaung, Blondina, et al.
Publicado: (2018)

Serum pentosidine levels in systemic lupus erythematosus
por: Nisihara, Renato, et al.
Publicado: (2020)

Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with Lupus
por: Du, Wenhan, et al.
Publicado: (2017)

Serum Levels of Three Angiogenic Factors in Systemic Lupus Erythematosus and Their Clinical Significance
por: Zhou, Ling, et al.
Publicado: (2014)

Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing
por: Ikeda, Takayuki, et al.
Publicado: (2011)

Serum galectin-3 and galectin-3 binding protein levels in systemic lupus erythematosus and cutaneous lupus erythematosus
por: Kalinska-Bienias, Agnieszka, et al.
Publicado: (2020)

Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus
por: Wang, Hongxu, et al.
Publicado: (2016)

Total Serum Calcium Level Is Negatively Correlated With Systemic Lupus Erythematosus Activity
por: Sha, Yeqin, et al.
Publicado: (2020)

Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells
por: Gruemmer, Ruth, et al.
Publicado: (2005)

Secretion of Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFlt1) Requires Arf1, Arf6, and Rab11 GTPases
por: Jung, Jae-Joon, et al.
Publicado: (2012)

Analysis of Adiponectin Gene Polymorphisms in Chinese Population with Systemic Lupus Erythematosus
por: Fang, Wen Liang, et al.
Publicado: (2010)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

MTHFR polymorphisms (rs1801133) and systemic lupus erythematosus risk: A meta-analysis
por: Zhou, Huang-yan, et al.
Publicado: (2020)

Correction: Secretion of Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFlt1) Requires Arf1, Arf6, and Rab11 GTPases
por: Jung, Jae-Joon, et al.
Publicado: (2012)

Levels of the macrophage migration inhibitory factor and polymorphisms in systemic lupus erythematosus: a meta-analysis
por: Sam, Napoleon Bellua, et al.
Publicado: (2019)

The Association of the GABRP Polymorphisms with Systemic Lupus Erythematosus
por: Kim, Hun-Soo, et al.
Publicado: (2015)

IKZF1 polymorphisms are associated with susceptibility, cytokine levels, and clinical features in systemic lupus erythematosus
por: Chen, Lin, et al.
Publicado: (2020)

Pre‐diagnostic levels of sVEGFR2, sTNFR2, sIL‐2Rα and sIL‐6R are associated with glioma risk: A nested case–control study of repeated samples
por: Wu, Wendy Yi‐Ying, et al.
Publicado: (2022)

Association of long noncoding RNAs expression levels and their gene polymorphisms with systemic lupus erythematosus
por: Li, Jun, et al.
Publicado: (2017)

Association of Plasma IL-32 Levels and Gene Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population
por: Wang, Yanyun, et al.
Publicado: (2016)

Meta-Analysis of Associations of IL1 Receptor Antagonist and Estrogen Receptor Gene Polymorphisms with Systemic Lupus Erythematosus Susceptibility
por: Cai, Li, et al.
Publicado: (2014)

Decreased serum level of soluble-leptin-receptor in patients with systemic lupus erythematosus
por: Bagheri, K, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sqjbfdgb3p4hfobos73lsjtqpc